Results 161 to 170 of about 148,285 (191)

Canadian donations and transfusion database (CANDAT): From blood donors to transfusion recipients

open access: yes
Transfusion, EarlyView.
Sheharyar Raza   +29 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Evergreened drugs or evergreened profits?

Journal of Evaluation in Clinical Practice, 2022
AbstractBackground: Branded drugs contribute disproportionately to high prescription drug spending. Pharmaceutical companies utilize patent extension “evergreening” techniques that contribute to high drug costs. Aims: This article describes various patent extension techniques and analyzes the tactic of combining generic drugs with branded drugs, using ...
Simran Siddalingaiah   +1 more
openaire   +2 more sources

Evergreening

Journal of Financial Economics, 2022
We develop a simple model of relationship lending where lenders have incentives for evergreening loans by offering better terms to less productive and more indebted firms. We detect such lending behavior using loan-level supervisory data for the United States.
Miguel Faria-e-Castro   +2 more
openaire   +1 more source

The state of Evergreen: Evergreen at three

Library Review, 2010
Purpose – The purpose of this paper is to look at how the library sector might benefit from open source, from the point of view of a current vendor of Evergreen, an open source library management software.Design/methodology/approach – The paper is based on the authors' experience in the library systems market.Findings – The next evolution of Evergreen ...
Robert E. Molyneux, Mike Rylander
openaire   +2 more sources

Radioprotectors – the Evergreen Topic

Chemistry & Biodiversity, 2013
AbstractTo protect organisms from ionizing radiation (IR), and to reduce morbidity or mortality, various agents, called radioprotectors, have been utilized. Because radiation‐induced cellular damage is attributed primarily to the harmful effects of free radicals, molecules with radical‐scavenging properties are particularly promising as radioprotectors.
Kuntić, Vesna   +4 more
openaire   +4 more sources

Making medicines evergreen [PDF]

open access: possibleBMJ, 2012
Andrew Hitchings, Emma Baker, and Teck Khong examine how drug companies maximise profits after patents expire and show why regulatory agencies, policy makers, and prescribers need to be alert to the use of these ...
Teck K Khong   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy